The Lupus Plasmapheresis Study Group: rationale and updated interim report.

Artificial organs

Volumn 20, Issue 4, 1996, Pages 356-359

  Euler, H H ^a   Schwab, U M ^a   Schroeder, J O ^a   Hasford, J ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

CLINICAL TRIAL; GERMANY; HEALTH CARE ORGANIZATION; HUMAN; IMMUNOLOGY; INFORMATION PROCESSING; INTERNATIONAL COOPERATION; ISOLATION AND PURIFICATION; MORTALITY; PLASMAPHERESIS; PRACTICE GUIDELINE; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED STATES;

ANTIBODIES; CLINICAL TRIALS; DATA COLLECTION; GERMANY; GUIDELINES; HUMANS; INTERNATIONAL COOPERATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; NATIONAL INSTITUTES OF HEALTH (U.S.); PLASMAPHERESIS; UNITED STATES;

EID: 0030113024     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1996.tb04459.x     Document Type: Review

References (33)